Drug-resistant tuberculosis trial ends enrolment after positive initial data

Patient enrolment on an-MSF sponsored clinical trial, TB-PRACTECAL, has ended early after an independent data safety and monitoring board indicated that the new MDR-TB regimen being studied by the trial is vastly superior to current care.

Patient enrolment on an-MSF sponsored clinical trial, TB-PRACTECAL, has ended early after an independent data safety and monitoring board indicated that the new MDR-TB regimen being studied by the trial is vastly superior to current care.